Rating History for Alnylam Pharmaceuticals (ALNY) by Raymond James
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/3/2026 | Martin Auster | Upgrade | Strong Buy (Outperform) |
420.00 (N/A) |
205.52 (254.95) |
24.05% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
